Figure 1.
Observed OS from ELIANA (infused tisagenlecleucel) vs MT103-205 (blinatumomab).

Observed OS from ELIANA (infused tisagenlecleucel) vs MT103-205 (blinatumomab).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal